Ibrutinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ibrutinib and local guidelines before prescribing.

BTK inhibitor

Mechanism

Bruton tyrosine kinase inhibitor.

Uses

CLL, mantle cell lymphoma, Waldenstrom macroglobulinaemia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bleeding, AF, hypertension, diarrhoea, infections.

Interactions

CYP3A4 inhibitors raise levels; anticoagulants increase bleeding.

Contraindications and cautions

Active bleeding, AF caution

Monitoring

FBC, ECG, BP

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid in severe liver impairment

Overdose and reversal

Supportive

Special advice

Hold before and after surgery; ECG and BP monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book